Back to the main directory
Press Release
- PyroGenesis Announces Contract Toward Titanium Powder Supply and Distribution Agreement with Asian Materials Company by GlobeNewsWire
- SUNation Energy Announces Review of Strategic Alternatives to Maximize Shareholder Value by GlobeNewsWire
- ScottsMiracle-Gro Completes Divestiture of Hawthorne Subsidiary by GlobeNewsWire
- Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles by GlobeNewsWire
- Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate by GlobeNewsWire
- Seres Therapeutics to Present at CARB-X Investor Day by GlobeNewsWire
- Nkarta to Participate in Needham Virtual Healthcare Conference by GlobeNewsWire
- Aurora Mobile Debuts Modellix: A Unified Gateway for Next-Gen AI Media Generation by GlobeNewsWire
- Occidental Announces Gulf of America Oil Discovery at Bandit by GlobeNewsWire
- New Era Energy & Digital Announces Pricing of $100 Million Public Offering of Common Stock by GlobeNewsWire
- Exodus Launches Exodus Pay to Let Users Spend, Send, and Earn Rewards from One App by GlobeNewsWire
- Electra Awards $7.8 Million in Construction Contracts for Refinery Infrastructure by GlobeNewsWire
- AGF lance « Capitol Signals », un bulletin disponible par abonnement by GlobeNewsWire
- Bombardier to Report First Quarter 2026 Financial Results and Host Annual General Meeting of Shareholders on April 30, 2026 by GlobeNewsWire
- FTI Consulting to Release First Quarter 2026 Results and Host Conference Call by GlobeNewsWire
- Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline by GlobeNewsWire
- InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor by GlobeNewsWire
- Weight Watchers Announces Board Committee Appointments by GlobeNewsWire
- Notice to Convene the Extraordinary General Meeting in RIAS A/S on 6 May 2026 by GlobeNewsWire
- Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents by GlobeNewsWire
- Solar A/S: Nr. 8 2026 Storaktionærmeddelelse by GlobeNewsWire
- Fusion von PDI und Robex auf dem Weg zur Umsetzung by GlobeNewsWire
- Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% by GlobeNewsWire
- Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026 by GlobeNewsWire
- Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026 by GlobeNewsWire